Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance

URN to cite this document:: urn:nbn:de:bvb:355-epub-554598
DOI to cite this document:: 10.5283/epub.55459

Harrer, Dennis Christoph

; Lüke, Florian

; Pukrop, Tobias

; Ghibelli, Lina ; Reichle, Albrecht

; Heudobler, Daniel

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 26 Jan 2024 16:56

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

The concept of post-therapy metastatic spread, cancer repopulation and acquired tumor cell resistance (M-CRAC) rationalizes tumor progression because of tumor cell heterogeneity arising from post-therapy genetic damage and subsequent tissue repair mechanisms. Therapeutic strategies designed to specifically address M-CRAC involve tissue editing approaches, such as low-dose metronomic ...